Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study-Reference-Cited by-同舟云学术

Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study

Published:2001-04-01 Issue:7 Volume:153 Page:628-631
ISSN:1476-6256
Container-title:American Journal of Epidemiology
language:en
Short-container-title:

Author:

Vermund Sten H.

Publisher

Oxford University Press (OUP)

Subject

Epidemiology

Link

http://academic.oup.com/aje/article-pdf/153/7/628/

Reference22 articles.

1. Vermund SH, Fisher RD, Hoff R, et al. Preparing for HIV vaccine efficacy trials: partnerships and challenges. AIDS Res Hum Retroviruses1993;9(suppl 1):S127–32.

2. Sheon AR. Overview: HIV vaccine feasibility studies. AIDS Res Hum Retroviruses1994;10(suppl 2):S195–6.

3. Seage GR III, Holte SE, Metzger D, et al. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol2001;153:619–27.

4. Berman PW. Development of bivalent rgp120 vaccines to prevent HIV type 1 infection. AIDS Res Hum Retroviruses1998;14(suppl 3):S277–89.

5. Francis DP, Gregory T, McElrath MJ, et al. Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3. AIDS Res Hum Retroviruses1998;14(suppl 3):S325–31.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies;Vaccine;2005-02

2. Recruitment and Baseline Epidemiologic Profile of Participants in the First Phase 3 HIV Vaccine Efficacy Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2004-11